Navigation Links
Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
Date:9/24/2007

Quark Expands Hearing Loss Program With Novel SiRNA Approaches To Noise-

Induced Hearing Loss With Its First Drug Candidate, AHLI-11, For The Prevention Of Chemotherapy-Induced Hearing Loss In Late Pre-IND Stage

FREMONT, Calif., Sept. 24 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel RNA interference-based therapeutics, announced today that it has signed a collaboration agreement with the University of Michigan Kresge Hearing Research Institute (http://www.khri.med.umich.edu/) to begin pre-clinical studies of several new siRNA compounds for the treatment of acute hearing loss associated with acoustic (noise-induced) trauma through the inhibition of Quark's novel targets. These pre-clinical studies will be led by Professor Yehoash Raphael, Ph.D., Department of Otolaryngology at the University of Michigan.

These studies will target several different siRNA-based drug candidates that work by way of inhibition of Quark's proprietary target genes for the prevention and treatment of acoustic trauma-induced acute hearing loss. The multi-stage, animal model study will assess the ability to deliver these siRNA compounds to relevant cochlear cells in the inner ear. The efficacy of the selected siRNA compounds before and after acoustic trauma, the residence time of siRNA in the inner ear cells, and the duration of the therapeutic siRNA effect will also be primary focuses of the studies.

Daniel Zurr, CEO of Quark Pharmaceuticals, commented, "The establishment of this significant research collaboration with the University of Michigan enables us to expand our research program aimed at preventing and treating hearing loss. With an estimated 28 million Americans having some degree of hearing loss, this is a significant medical issue in the United States and throughout the world. Moreover, hearing loss is an u
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNewswir...ay announced that on November 5, 2009, it received...q") stating that the Nasdaq Hearing Panel has gran... NASDAQ Global Market subject to the condition tha...er 31, 2009, the proposed merger (the "Merger") co...
(Date:11/8/2009)..., AARP Praises House Passage of Health Care Ref...then Medicare, improve coverage for all Americans ...re/ -- Today the United States House of Representa...on that would strengthen Medicare for seniors and ...ces millions of Americans out of affordable health...
(Date:11/6/2009)..., DURHAM, N.C., Nov. 6 ... OXBO) today announced that a previously approved ... at the start of trading on Monday, Nov. 9, 2009 o...peutics, Inc. shares will trade under the new symb...er, 69207P 20 9, when the split becomes effective....
Breaking Medicine Technology:Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3New cancer drug test promises safer and more effective clinical trials 10053 1New cancer drug test promises safer and more effective clinical trials 10053 2New cancer drug test promises safer and more effective clinical trials 10053 3Ultrasound can predict tumor burden and survival in melanoma patients 58115 1Ultrasound can predict tumor burden and survival in melanoma patients 58115 2Ultrasound can predict tumor burden and survival in melanoma patients 58115 3Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 1Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 2
...r to Demonstrate Significant Survival Benefit in,L...FirstCall/ -- Bayer,HealthCare Pharmaceuticals Inc...hat Nexavar(R) (sorafenib) tablets significantly,e...llular carcinoma,(HCC), or primary liver cancer ve...=0.0006). Results were presented at the 43rd,annua...
...--(BUSINESS WIRE)--Jun 4, 2007 - GenVec, Inc.,(Nas...y safety and,efficacy data from the clinical devel...s presented in a poster session on,gastrointestina...y,for Clinical Oncology in Chicago, IL by Dr. Mitc... discussion of the posters then,concluded the Satu...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 2GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 3GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 4
(Date:11/9/2009)... March of Dimes Names 2010 National Ambassador ...wswire/ -- Joshua Hoffman of Weston, Fla., was bor...that doctors could not say whether he would surviv...Today, the 6-year-old was named March of Dimes 201...e Hoffman, recalls, "My first minutes of motherhoo...
(Date:11/9/2009)... DETROIT, Nov. 9 For th... Cancer Center has been selected the most preferre...according to a survey by the National Research Cor...gi-bin/prnh/20071106/KARMANOSLOGO ) ,, The ann...naire between September 2008 and August 2009. Surv...
(Date:11/9/2009)... study reports some people went from incapacitated... (HealthDay News) -- Electrical stimulation of a c...eatment for severe depression, say German research... accumbens area of the brains of 10 people. This ...t ensures that people remember good experiences an...
(Date:11/9/2009)... NEW YORK, Nov. 9 /PRNewswire/ -- Phoenix Hous...rug abuse treatment and prevention program, announ... nationally and internationally recognized leader ...f Clinical Officer, effective January 1, 2010. ,...substance abuse treatment research and her work ha...
(Date:11/9/2009)... ROCHESTER, Minn., Nov. 9 /PRNewswire-USNewswire/ ... surgery for vaginal prolapse dramatically red...e findings are being presented this week at the No...ociation in Scottsdale, Ariz. ,, (Logo: http... ) ,, VIDEO ALERT : Additional audio and vide...
Breaking Medicine News(10 mins):Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3
...cientists at MIT and Harvard University and suppor...nd Infectious Diseases, a component of the Nationa...om 43 P. falciparum-infected malaria patients in S...ly 6,000 P. falciparum genes were switched on or o...
...vember 28, 2007 - You have just been prescribed a ...bel says: "take one tablet by mouth twice daily fo...your medicine" This might be easy for you to answe...e. , Ninety million Americans about half of the ...
...ted to building the multidisciplinary drug abuse r...he focus of a five-year, $2.3 million grant awarde...f Drug and Social Policy Research (ODSPR). , Fun...ill support the creation of the Minority Instituti...
...s that deliver alternative energy sources to the e... diabetes, researchers say. , The transporters, S... blood-retinal barrier, delivering energy sources ...nty of glucose but the inability of cells to use i...
...l mammography cut rate of false-positive results, ...Day News) -- A 3-D view of breast tissue may give ...ancers, according to a trial of a new technology c...d Getty, a division scientist at BBN Technologies ...
...7 (Oakland, CA) The National Heart Lung and Blood... five years to establish a collaborative Cardiovas...ill leverage the collective cardiovascular experti...ch Network to better study the epidemiology, preve...
Other Medicine News:Health News:System of simplified, standardized dosing instructions for prescription drug labels proposed 2Health News:System of simplified, standardized dosing instructions for prescription drug labels proposed 3Health News:National Institutes of Health grant to fund drug abuse research at UH 2Health News:Transporters may help delay diabetes-related retinal damage 2Health News:Transporters may help delay diabetes-related retinal damage 3Health News:3-D Breast Imaging May Improve Cancer Detection 2Health News:3-D Breast Imaging May Improve Cancer Detection 3Health News:National Heart Lung and Blood Institute creates national network to study cardiovascular disease 2
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: